Enable Injections enters strategic partnership with large drug maker

Enable Injections disclosed today that the Evendale medical device maker has entered into a development agreement with the biotechnology and pharmaceuticals firm Genentech.

Fast-growing Enable Injections is developing a disposable device called enFuse that will allow patients to self-inject a large dose of a prescription drug with the touch of a button. “En” stands for Enable, and “fuse” is short for infuse.

Click here to read the complete article.

Story excerpt provided by Cincinnati Business Courier.

Written by Barrett J. Brunsman.

Originally published August 21, 2019.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: